In this study, PSMA expression in tumor-associated neovasculature was greatest among ccRCC tumors (76%), followed by renal oncocytoma (53%) and chromophobe RCC (31%). This evidence concerns the gene FOLH1 and nonpapillary renal cell carcinoma.